1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

Adenocarcinoma of lung

  1. Functional characterization of human cancer-derived TRKB mutations.
  2. Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery.
  3. Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.
  4. Epidermal growth factor receptor mutations as a prognostic factor in Korean patients with advanced lung adenocarcinoma who had not been treated with received epidermal growth factor receptor tyrosine kinase inhibitors.
  5. [Application of bio-chip in lung cancer research].
  6. Increased microcirculation in subepithelial invasion of lung cancer.
  7. Importance of molecular features of non-small cell lung cancer for choice of treatment.
  8. Loss of aquaporin-4 expression and putative function in non-small cell lung cancer.
  9. [Sequence-dependent effect of docetaxel with gefitinib on the proliferation and signal protein expression of human lung adenocarcinoma cell SPC-A1].
  10. [miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
  11. [RNA Interference targeting GRP75 decreases cisplatin resistance in human lung adenocarcinoma cell].
  12. Papulopustular eruptions in a 32-year-old woman after lung cancer treatment.
  13. Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspiration.
  14. Targeted therapy: an evolving world of lung cancer.
  15. Endometrial metastasis of lung adenocarcinoma: a case report.
  16. A novel monocarbonyl analogue of curcumin, (1E,4E)-1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via activation of endoplasmic reticulum stress signaling pathway.
  17. Dramatic postchemotherapy reduction of left atrial involvement from lung cancer.
  18. Targeted therapies and other agents as first-line maintenance and beyond: particular benefit in pulmonary adenocarcinoma patients.
  19. Effects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells.
  20. Runx3 is a crucial regulator of alveolar differentiation and lung tumorigenesis in mice.